Arzu Selen

1.2k total citations
30 papers, 931 citations indexed

About

Arzu Selen is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Analytical Chemistry. According to data from OpenAlex, Arzu Selen has authored 30 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 11 papers in Pharmaceutical Science and 7 papers in Analytical Chemistry. Recurrent topics in Arzu Selen's work include Drug Solubulity and Delivery Systems (11 papers), Pharmaceutical studies and practices (9 papers) and Analytical Methods in Pharmaceuticals (7 papers). Arzu Selen is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Pharmaceutical studies and practices (9 papers) and Analytical Methods in Pharmaceuticals (7 papers). Arzu Selen collaborates with scholars based in United States, Denmark and United Kingdom. Arzu Selen's co-authors include Peter G. Welling, Anette Müllertz, Gordon L. Amidon, Barbara G. Painter, Mario Ángel-González, P.J. Wyld, R. A. Yates, Mitch Dowsett, Sarah Gordon and Jennifer Dressman and has published in prestigious journals such as PEDIATRICS, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

Arzu Selen

29 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Selen United States 18 253 238 200 162 139 30 931
T. Thanga Mariappan India 19 135 0.5× 172 0.7× 216 1.1× 240 1.5× 119 0.9× 32 776
L.F. Lacey United Kingdom 19 127 0.5× 133 0.6× 249 1.2× 164 1.0× 223 1.6× 36 1.5k
Nasir Idkaidek Jordan 17 174 0.7× 134 0.6× 213 1.1× 111 0.7× 109 0.8× 70 840
Arlyn W. Kinkel United States 14 176 0.7× 185 0.8× 187 0.9× 80 0.5× 102 0.7× 27 794
A. Domínguez‐Gil Spain 19 513 2.0× 355 1.5× 96 0.5× 152 0.9× 90 0.6× 148 1.4k
André J. Jackson United States 19 165 0.7× 142 0.6× 106 0.5× 102 0.6× 93 0.7× 46 800
Kirstin Thelen Germany 20 186 0.7× 259 1.1× 248 1.2× 324 2.0× 191 1.4× 26 1.3k
Douglas S. Greene United States 20 487 1.9× 154 0.6× 179 0.9× 219 1.4× 236 1.7× 66 1.4k
Mario Eandi Italy 18 124 0.5× 93 0.4× 134 0.7× 131 0.8× 199 1.4× 55 879
D.G. Perrier United States 21 223 0.9× 101 0.4× 208 1.0× 193 1.2× 331 2.4× 45 1.3k

Countries citing papers authored by Arzu Selen

Since Specialization
Citations

This map shows the geographic impact of Arzu Selen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Selen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Selen more than expected).

Fields of papers citing papers by Arzu Selen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Selen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Selen. The network helps show where Arzu Selen may publish in the future.

Co-authorship network of co-authors of Arzu Selen

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Selen. A scholar is included among the top collaborators of Arzu Selen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Selen. Arzu Selen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selen, Arzu, et al.. (2025). Differential effects of amlodipine and ramipril on fluid compartments, sodium balance, and edema in hypertensive patients. Journal of the Renin-Angiotensin-Aldosterone System. 26.
2.
Khong, Yuet Mei, Jing Liu, Jack Cook, et al.. (2021). Harnessing formulation and clinical pharmacology knowledge for efficient pediatric drug development: Overview and discussions from M-CERSI pediatric formulation workshop 2019. European Journal of Pharmaceutics and Biopharmaceutics. 164. 66–74. 1 indexed citations
3.
Selen, Arzu, et al.. (2021). Drug solubilization during simulated pediatric gastro-intestinal digestion. European Journal of Pharmaceutical Sciences. 162. 105828–105828. 3 indexed citations
4.
Selen, Arzu, Anette Müllertz, Filippos Kesisoglou, et al.. (2020). Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products. The AAPS Journal. 22(5). 97–97. 3 indexed citations
5.
6.
Sassene, Philip, et al.. (2017). Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants. European Journal of Pharmaceutical Sciences. 109. 191–199. 17 indexed citations
7.
Berthelsen, Ragna, et al.. (2016). In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants). AAPS PharmSciTech. 18(2). 317–329. 38 indexed citations
8.
Otsuka, K., Christian Wagner, Arzu Selen, & Jennifer Dressman. (2015). Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro–in-silico–in-vivo approach. Journal of Pharmacy and Pharmacology. 67(5). 651–665. 23 indexed citations
9.
Selen, Arzu, Paul A. Dickinson, Anette Müllertz, et al.. (2014). The Biopharmaceutics Risk Assessment Roadmap for Optimizing Clinical Drug Product Performance. Journal of Pharmaceutical Sciences. 103(11). 3377–3397. 45 indexed citations
10.
Wagner, Christian, Kirstin Thelen, Stefan Willmann, Arzu Selen, & Jennifer Dressman. (2013). Utilizing In Vitro and PBPK Tools to Link ADME Characteristics to Plasma Profiles: Case Example Nifedipine Immediate Release Formulation. Journal of Pharmaceutical Sciences. 102(9). 3205–3219. 27 indexed citations
11.
Fotaki, Nikoletta, et al.. (2013). Survey Results for In Vitro-In Vivo Correlations (IVIVC): Critical Variables for Success. Dissolution Technologies. 20(2). 48–50. 8 indexed citations
12.
Gordon, Sarah, Kaisa Naelapää, Jukka Rantanen, et al.. (2012). Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging. Pharmaceutical Development and Technology. 18(6). 1407–1416. 30 indexed citations
13.
Selen, Arzu, Anette Müllertz, Paul A. Dickinson, et al.. (2010). Meeting Report: Applied Biopharmaceutics and Quality by Design for Dissolution/Release Specification Setting: Product Quality for Patient Benefit. The AAPS Journal. 12(3). 465–472. 23 indexed citations
14.
Rodriguez, William, Arzu Selen, Debbie Avant, et al.. (2008). Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned. PEDIATRICS. 121(3). 530–539. 114 indexed citations
15.
Ward, Robert M., W.E. Benitz, Daniel K. Benjamin, et al.. (2006). Criteria supporting the study of drugs in the newborn. Clinical Therapeutics. 28(9). 1385–1398. 18 indexed citations
16.
Yates, R. A., et al.. (1996). Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers. British Journal of Cancer. 73(4). 543–548. 74 indexed citations
17.
Selen, Arzu, et al.. (1990). Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease.. PubMed. 26(2). 231–4. 26 indexed citations
18.
Selen, Arzu, Curtis A. Johnson, Mark Rogge, William A. Craig, & Peter G. Welling. (1985). Absorption of theophylline from two sustained release formulations. Biopharmaceutics & Drug Disposition. 6(2). 217–221. 1 indexed citations
19.
Selen, Arzu, et al.. (1982). Pharmacokinetics of Probenecid Following Oral Doses to Human Volunteers. Journal of Pharmaceutical Sciences. 71(11). 1238–1242. 73 indexed citations
20.
Welling, P. G., Scott N. Dean, Arzu Selen, M. J. Kendall, & R. Wise. (1979). Probenecid: an unexplained effect on cephalosporin pharmacology.. British Journal of Clinical Pharmacology. 8(5). 491–495. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Thanga Mariappan Breakdown of academic impact, for papers by L.F. Lacey Breakdown of academic impact, for papers by Nasir Idkaidek Breakdown of academic impact, for papers by Arlyn W. Kinkel Breakdown of academic impact, for papers by A. Domínguez‐Gil Breakdown of academic impact, for papers by André J. Jackson Breakdown of academic impact, for papers by Kirstin Thelen Breakdown of academic impact, for papers by Douglas S. Greene Breakdown of academic impact, for papers by Mario Eandi Breakdown of academic impact, for papers by D.G. Perrier
Rankless by CCL
2026